Stifel Maintains Hold on Globus Medical, Lowers Price Target to $80

Benzinga Newsdesk www.benzinga.com Negative 66.4%

Neg 66.4% Neu 0% Pos 0%

Stifel analyst Tom Stephan maintains Globus Medical (NYSE:GMED) with a Hold and lowers the price target from $95 to $80.